HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid | HCID 58484719 | — |
| Reactant | 1-(3-Cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine hydrochloride | HCID 67380779 | — |
| Product | (R)-3-{4-[4-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochloride | HCID 67380940 | 111.9% |
Reaction Steps
By reaction and treatment in the same manner as in Example 87 and using (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (221 mg) described in Preparation Example 37 and 1-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine hydrochloride (615 mg) described in Preparation Example 76, the title compound (571 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08354401B2 |
| Source dataset | uspto-grants-2013_01 |
| ORD ID | ord-086d19a35caf4e8eb6b96d3be9a694d9 |
| Source note | uspto-grants-2013_01 |